title: [Hormone replacement therapy and ovarian tumors].
abstract: OBJECTIVE
  Analysis of risk and protective factors and hormone replacement therapy in the aethiology and pathogenesis of ovarian cancer. The role of hormone replacement therapy in the complex treatment in women with ovarian cancer is discussed.
  
  
  METHODS
  Reviewed article.
  
  
  METHODS
  Department of Obstetrics and Gynaecology, University Hospital Ostrava.
  
  
  METHODS
  Analysis of epidemiological studies.
  
  
  CONCLUSIONS
  The role of hormone replacement therapy as a risk factor of ovarian cancer has not been confirmed. Hormone replacement therapy as a part of supportive and symptomatic therapy has been acceptable in a great deal of patients with ovarian cancer.
authors: Porodnicko-gynekologická klinika, FNsP Ostrava.
authors: L
authors: L
authors: Sevcík
authors: J
authors: J
authors: Klát
authors: P
authors: P
authors: Koliba
mesh_terms: D015914:Estrogen Replacement Therapy / Q000009:adverse effects*; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000139:chemically induced* / Q000517:prevention & control; D012307:Risk Factors